Although this study was limited by the small number of cases and short follow-up periods after operation, the results indicate that c-MYC expression might be an early recurrence predictive marker for colorectal cancer patients following 5-FU-based adjuvant chemotherapy. Here, MYC is linked to colorectal cancer.